Lexaria Bioscience Corp [LEXX] stock prices are down -1.34% to $2.21 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LEXX shares have gain 5.24% over the last week, with a monthly amount drifted -6.75%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Lexaria Bioscience Corp [LEXX] has been fluctuating between $1.27 and $6.85 over the past year. Lexaria Bioscience Corp [NASDAQ: LEXX] shares were valued at $2.21 at the most recent close of the market.
Analyzing the LEXX fundamentals
The Lexaria Bioscience Corp [NASDAQ:LEXX] reported sales of 0.46M for trailing twelve months, representing a drop of -9.82%. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at -12.39%, Pretax Profit Margin comes in at -12.51%, and Net Profit Margin reading is -12.48%. To continue investigating profitability, this company’s Return on Assets is posted at -0.65, Equity is -0.82 and Total Capital is -0.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.13 points at the first support level, and at 2.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.29, and for the 2nd resistance point, it is at 2.38.
Ratios To Look Out For
It’s worth pointing out that Lexaria Bioscience Corp [NASDAQ:LEXX]’s Current Ratio is 7.18. Also, the Quick Ratio is 7.18, while the Cash Ratio stands at 5.91. Considering the valuation of this stock, the price to sales ratio is 83.84, the price to book ratio is 4.35.
Transactions by insiders
Recent insider trading involved CHRISTOPHER RICHARD, Chief Executive Officer, that happened on Dec 03 ’24 when 27172.0 shares were purchased. Chief Executive Officer, CHRISTOPHER RICHARD completed a deal on Dec 02 ’24 to buy 22828.0 shares. Meanwhile, Director TURKEL CATHERINE C. bought 1600.0 shares on Aug 12 ’24.
